• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Stock Trend Alerts

Essential Market Ideas and Investing Strategies

  • Newsletter Reviews
  • Hot Stocks
  • Technology
  • Financial News
  • Secrets of the Pros
  • Analysis
Home » Will Reddit Hype Propel these Biotech Penny Stocks?

Will Reddit Hype Propel these Biotech Penny Stocks?

We’re at the start of a brand new week and a whole new list of penny stocks to watch. One of the popular places that retail traders are searching is on Reddit. The social media discussion platform has become a notable hang-out for traders. That’s ever since the massive short-squeeze triggered GameStop, and others were traced to its origins on the platform. Needless to say, the word is out. Now, traders are searching for some of the most actively discussed names in the market.

However, there is something to keep in mind, especially if this is one of the reasons that brought you into the market in the first place. What is this one thing, you might ask? It’s the fact that not everything on social media is true (mind-blowing, I know). There are plenty of Redditors with real information genuinely contributing to the Reddit community.

But some use it for other means that are more deceiving to investors. We saw this most recently on Twitter, where a so-called “trusted name” by some was using their following for their own self-interests. If there’s another thing that has come to light due to all of this retail hype, it’s that social media is powerful. Word spreads like wildfire. Now organizations like the Securities & Exchange Commission have begun cracking down on bad actors.

Reddit Penny Stocks To Watch

Regardless of this, it’s never a bad idea to do your own research. If you see one of the penny stocks getting hyped up on social media, it doesn’t hurt to do some digging and understand why it’s making a move (besides the hype factor). Research the filings, recent news (if any), and basically don’t take anything for face value.

While we do our best to give some insight into trending penny stocks, it’s essential to get a full scope, and research is where that begins. With this in mind, let’s take a look at some of the trending penny stocks on Reddit. Then you can decide if they’ll be on your “buy” or “avoid” list at the start of the week.

  • ConforMIS Inc. (NASDAQ: CFMS)
  • Neovasc Inc. (NASDAQ: NVCN)
  • Seneca Biopharma (NASDAQ: SNCA)

ConforMIS Inc.

Since December, CFMS stock has added more than 60% in value. As a medical technology company, ConforMIS provides joint replacement systems for its patients. This includes both knee- and hip-implants that can have superior results compared to traditional joint replacement methods. One of its flagship products, known as the iTotal CR knee replacement system, has shown patients to have greater long-term satisfaction and results than off-the-shelf implants. It offers custom and personalized options.

[Alert: Look at this RARE 5100% Chart!]

ConforMIS recently announced that its technology is much more cost-effective than the typical implants that one would receive. Dr. Paul Manner, a joint replacement professor at the University of Washington in Seattle, stated that “we’ve been very pleased with the early outcomes for patients with the Conformis knee. Patients report that the knee feels more like a normal, healthy joint; they recover more quickly and are back to regular activity substantially faster than with traditional, off-the-shelf implants.”

This is great news for investors because it shows that ConforMIS disrupts this area of the medical tech market. In its fourth-quarter report, announced earlier in the month, CFMS brought in product revenue of $16.5 million. While this is a decrease of 16% year over year, this makes sense given the lessened demand for elective medical procedures during the pandemic.

So now that vaccines are in distribution, CFMS could see its market begin to grow. While this does depend on how quickly it can commercialize, in the meantime, CFMS could be a penny stock to watch.

(source: pennystocks.com)

Neovasc Inc.

Neovasc Inc. is a medical device provider. The company develops a large range of products for the cardiovascular marketplace. This includes minimally invasive transcatheter mitral valve replacements, as well as devices for the treatment of refractory angina. One of its flagship products known as the Neovasc Reducer is currently in limited availability in the U.S., but it is commercially available in Europe right now.

[Breakthrough: Warren Buffett made $12 billion with the idea behind this simple technique]

Its product, Tiara, for the transcatheter treatment of mitral valve disease, is in clinical trials in the U.S., Europe, Canada, and Israel. Only a week or so ago, Neovasc announced its fourth quarter and full-year 2020 results. In the report, it generated roughly $514,000 in revenue during Q4 and $1.96 million for the entire year. Additionally, it announced several milestones, such as the first Neovasc Reducer implants in France.

In December of 2020, Neovasc engaged in a $6.1 million direct registered share offering. Fred Colen, CEO of Neovasc, stated that “Neovasc continued to advance its efforts to commercialize the Reducer and further develop the Tiara devices in the fourth quarter. We are encouraged by the results of the quarter despite the impact from Covid-19. We believe there is clearly strong underlying demand for Reducer.”

While 2020 may not have been a banner year for the company, it has some big moves currently in the works for 2021. This includes a $72 million offering that it announced in February. Also, the company continues to make big strides in the European medical tech market.

(source: pennystocks.com)

Seneca Biopharma

Shares of Seneca Biopharma had a very active post-market session on Friday afternoon. While SNCA stock closed at $1.64 during the regular session, the penny stock climbed as high as $1.93 before the final bell rang. There weren’t any headlines hitting the PR wire. However, if you’ve been reading out articles on Seneca, you’re probably already familiar with one of the major catalysts recently.

To give you some background, if you’re unfamiliar, in December, Seneca entered into a merger agreement with Leading BioSciences, Inc. Once completed, the company will change its ticker symbol PALI and its name to Palisade Bio, Inc. The newly formed company’s main focus will be on advancing Leading’s pipeline Phase-3 ready asset, LB1148. In clinical studies, the company will evaluate LB1148’s potential to restore normal GI function following major surgery and reduce certain postoperative complications such as abdominal adhesions.

[Learn More: these stocks can quickly multiply in price 5x, 10x, 100x, or much higher…]

The recent momentum could be based on speculation on an event this week. March 24th marks the date of Seneca’s special shareholder meeting to vote on several approvals. This includes effecting a reverse split of common stock. According to the company, “The Seneca Board believes that analysts at many brokerage firms do not monitor the trading activity or otherwise provide coverage of lower-priced stocks and that most investment funds are reluctant to invest in lower-priced stocks.”

In light of the special meeting and Friday’s momentum, will SNCA be on your list of penny stocks to watch this week?

(source: pennystocks.com)

[See Also: The Single Easiest Way to Multiply Your Money by 179x]

Read more from J. Samuel at PennyStocks.com

You Might Also Like...

  • Insiders are Buying Up these High-Yield Dividend Stocks
  • Profit from the Global Transition to Electric Vehicles with these 5 Penny Stocks
  • Three Penny Stocks to Add to Your Watchlist in 2022
  • 3 Diverse Penny Stocks with Major Gain Potential...

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Subscribe to Stock Trend Alerts

By submitting your email address, you give Stock Trend Alerts permission to deliver investment research to your email inbox. Privacy Policy | How It Works

Popular Posts

  • Martin Weiss Docket No. OP–1670: 12 Inflation-Beating Stocks
  • Jim Rickards – The Return of American Energy: Profit from the Green Lie
  • Louis Navellier Growth Investor: Secure Your Savings From The CBDC
  • Biden’s Big Blackout: Jim Rickards’ Strategic Intelligence Review
  • Dan Ferris Report: The Only Stocks That Can Safely 8X Your Money During America’s “Dead-Zone”
  • Marc Lichtenfeld Oxford Income Letter: The #1 Oil and Gas Income Play for 2023
  • Eric Fry’s Investment Report: The Revenge of the Heartland #1 AI Powered EV Stock
  • Marc Chaikin Reveals Biggest Stock Prediction of his 50-year Career on Wall Street

Recent Posts

  • Dylan Jovine Search & Destroy: 3 AI Software Stocks Revolutionizing Warfare
  • Alpha Investor Charles Mizrahi: Energy Fortunes No. 1 Stock Recommendation
  • Luke Lango’s Innovation Investor: Area 52 The Quantum Windfall Report
  • Nick Black Digital Fortunes Network: Four Digital Pyramid Stocks for Generational Wealth
  • Review: Porter Stansberry and The Big Secret on Wall Street – The Forever Term

Topics

AAPL Advertorial Amazon AMZN Artificial Intelligence Battery Bear Market Biotech Bitcoin Blockchain Clean Energy Cloud Computing Coronavirus COVID Creative Cryptocurrency Dividends E-Commerce Electric Vehicles Elon Musk Energy Ethereum Gold Growth Stocks Inflation Interest Rates International Jeff Brown Louis Navellier Market Crash MSFT Oil and Gas Options Prediction President Biden Recession Retirement Russia Semiconductor Supply Chain Tesla The Fed TSLA Volatility Warren Buffett

Copyright © 2023 · Stock Trend Alerts - Essential Market Moves and Investing Ideas

Nothing on this website should be considered personalized financial advice. Any investments recommended here in should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security.

Stock Trend Alerts, its managers, its employees, affiliates and assigns (collectively "The Company") do not make any guarantee or warranty about the advice provided on this website or what is otherwise advertised above.

The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. The Company is not affiliated with, nor does it receive compensation from, any specific security.

To the maximum extent permitted by law, the Company disclaims any and all liability in the event any information, commentary, analysis, opinions, advice and/or recommendations provided herein prove to be inaccurate, incomplete or unreliable, or result in any investment or other losses.

About Us | How it Works | Privacy Policy | Terms and Conditions | Contact Us